In Chilmark Research’s report due out this week, we examine solutions for the patient-consumer experience with a critical lens and an eye to the future.
HIMSS’19: Real Value in Telehealth and Virtual Care
This is the second in a series of blog posts recapping HIMSS'19; you can read all our coverage...
HIMSS’19: What to Expect, What I Hope to Find
Next week, most of the healthcare IT industry will descend on Orlando to attend HIMSS’19. This is...
Webinar – Telehealth 2018: Healthcare Beyond the Exam Room
In this webinar, Chilmark President John Moore presents key findings from our...
Revisiting Our 2018 Predictions
As is our custom here, we like to look back on our predictions for the closing year and see just...
How will Proposed Changes to CMS Telehealth Reimbursement Affect Adoption?
On Friday, October 26, the Centers for Medicare and Medicaid Services (CMS) announced several rule changes that affect how telehealth services will be covered under Medicare Advantage (MA) and the Medicare prescription drug program (Part D). These changes are in direct response to the Bipartisan Budget Act of 2018, which eliminated historical restrictions on telehealth reimbursement, and are intended to “improve quality of care and provide more plan choices for MA and Part D enrollees.”